Neoadjuvant cetuximab plus tislelizumab combined with chemotherapy in pMMR RAS/BRAF wild-type (wt) locally advanced rectal cancer (LARC): A prospective, multicenter, phase II study.

Authors: Gang Liu, Xiaoping Li, Anqi He, Kaiyu Li, Heyuan Niu

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps3640

Source: Full article

---

Abstract

TPS3640